Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
View Patent ↗The present invention provides immunogenic compositions having one or more polysaccharide-protein conjugates in which polysaccharides obtained from bacterial capsules are conjugated to diphtheria toxin fragment B (DTFB) or a variant thereof. The immunogenic compositions may be multivalent pneumococcal polysaccharide conjugate compositions in which polysaccharides from one or more Steptococcus pneumoniae serotypes are conjugated to diphtheria toxin fragment B (DTFB) and, optionally, additional polysaccharides from one or more different Steptococcus pneumoniae serotypes are conjugated to one or more other carrier proteins.
1. An immunogenic composition comprising a Streptococcus pneumoniae serotype 3 polysaccharide-carrier protein conjugate, wherein the carrier protein is diphtheria toxin fragment B (DTFB) or a variant thereof, wherein the variant has at least 90%, 95% or 99% sequence homology to the DTFB carrier protein, including deletions, substitutions and additions; and further comprising additional Streptococcus pneumoniae polysaccharide-carrier protein conjugates, wherein the carrier protein is not a DTFB carrier protein or a variant thereof, wherein the variant has at least 90%, 95% or 99% sequence homology to the DTFB carrier protein, including deletions, substitutions and additions.
2. The immunogenic composition of claim 1 wherein the carrier protein of the Streptococcus pneumoniae serotype 3 polysaccharide-carrier protein conjugate is DTFB.
3. The immunogenic composition of claim 1 , wherein the additional Streptococcus pneumoniae polysaccharide-carrier protein conjugates consist of polysaccharides selected from one or more of serotypes 1, 2, 4, 5, 6A, 6B, 6C, 6D, 7B, 7C, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15A, 15B, 15C, 16F, 17F, 18C, 19A, 19F, 20, 21, 22A, 22F, 23A, 23B, 23F, 24F, 27, 28A, 31, 33F, 34, 35A, 35B, 35F, and 38.
4. The immunogenic composition of claim 1 wherein the carrier protein of the additional Streptococcus pneumoniae polysaccharide-carrier protein conjugate is CRM 197 .
5. The immunogenic composition of claim 1 , wherein the additional Streptococcus pneumoniae polysaccharide-carrier protein conjugates consist of polysaccharides selected from serotypes 1, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F and the carrier protein is CRM 197 .
6. The immunogenic composition of claim 5 , further comprising an adjuvant.
7. The immunogenic composition of claim 6 , wherein the adjuvant is an aluminum-based adjuvant.
8. The immunogenic composition of claim 7 , wherein the adjuvant is selected from the group consisting of aluminum phosphate, aluminum sulfate and aluminum hydroxide.
9. The immunogenic composition of claim 8 , wherein the adjuvant is aluminum phosphate.
10. The immunogenic composition of claim 9 , wherein the immunogenic composition is formulated to contain: 4 μg/mL of each polysaccharide, except for 6B which contains 8 μg/mL of polysaccharide; about 64 μg/mL CRM 197 carrier protein; about 4 μg/mL of DTFB carrier protein; 0.25 mg/mL aluminum phosphate adjuvant; 150 mM sodium chloride; 20 mM L-histidine buffer; and 0.2% w/v polysorbate-20 (PS-20).